放射治疗中剂量带预测的可行性研究:预测计划剂量谱
该研究提出「剂量带预测」方法,利用上/下带损失训练三维神经网络模型,为每个体素预测理想剂量谱。在104例鼻咽癌螺旋断层治疗、54例宫颈癌IMRT和37例宫颈癌VMAT数据中验证,上/下带剂量分别倾向高于/低于临床剂量,中线剂量与临床剂量一致。
要点
- 上带/下带模型预测剂量分别倾向高于/低于临床剂量,形成预测剂量谱。
- 中线剂量(上/下带平均值)与临床剂量一致,数据集1-3的平均差异分别为-0.40%、-1.62%、-0.59%。
- 数据集3中剂量带自动计划与MSE自动计划在危及器官的平均差异为-2.67%。
核心结论
- 剂量带预测成功预测了剂量谱,使自动计划和质量保证灵活且高质量。
研究设计与样本
- 可行性研究,纳入104例鼻咽癌螺旋断层治疗病例(数据集1)、54例宫颈癌IMRT病例(数据集2)和37例宫颈癌VMAT病例(数据集3)。
- 使用三维神经网络中的上带/下带损失建立上带模型(UBM)和下带模型(LBM)。
- UBM/LBM预测的最大/最小合理剂量定义每个体素的理想剂量谱。
- 在数据集3中开展基于剂量带的自动计划(Auto-plandose-band)尝试,并与MSE模型(Auto-planMSE)比较。
主要发现
- UBM/LBM剂量倾向高于/低于临床剂量,形成预测剂量谱。
- 中线剂量(上/下带平均值)与临床剂量一致。
- 数据集1中上带、中线、下带对PTV和OAR的平均差异分别为3.66%、-0.40%、-4.48%。
- 数据集2中上带、中线、下带对PTV和OAR的平均差异分别为2.40%、-1.62%、-5.57%。
- 数据集3中上带、中线、下带对PTV和OAR的平均差异分别为2.18%、-0.59%、-3.31%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The current deep learning-based dose prediction methods only predict one dose distribution. If the predicted dose is inaccurate, no additional options can be selected. To overcome this limitation, we propose a novel dose prediction method called "dose-band prediction," which provides a spectrum of predicted dose distributions for planning and quality assurance (QA) purposes. MATERIAL AND METHODS: We utilized Upper/Lower-band losses in 3D neural networks to establish the Upper/Lower-band models (UBM/LBM). The maximum/minimum rational dose predicted in UBM/LBM defined the ideal dose spectrum for each voxel. We enrolled 104 nasopharyngeal carcinoma cases with tomotherapy (dataset 1), 54 cervical carcinoma cases with IMRT (dataset 2), and 37 cervical carcinoma cases with VMAT (dataset 3) in the study. Moreover, a dose band-based auto planning (Auto-plandose-band) attempt was carried out in dataset 3, compared with the MSE model (Auto-planMSE). RESULTS: The UBM/LBM doses tend to be higher/lower than the clinical dose, forming a predicted dose spectrum. The Middle-line dose represents the average of the Upper/Lower-band, which was consistent with the clinical dose. The mean differences of the planning target volumes (PTVs) and organs at risk (OARs) for the Upper-band, Middle-line, and Lower-band in Dataset 1 were 3.66 %, -0.40 %, and -4.48 % in Dataset 2, they were 2.40 %, -1.62 %, and -5.57 %; in Dataset 3, they were 2.18 %, -0.59 %, and -3.31 %. When PTVs meet prescription, the mean difference between Auto-plandose-band and Auto-planMSE in OARs was -2.67 %. CONCLUSION: The dose-band prediction successfully predicted a spectrum of doses, making auto-planning and QA flexible and high quality.
引用
- Liu Y, Chen Z, Zhou Q, et al. A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose. Radiother Oncol. 2024. PMID: 39489427. doi:10.1016/j.radonc.2024.110593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。